Cite
HARVARD Citation
Massachi, S. et al. (2021). Cost savings with hemin versus givosiran for the treatment of patients with acute intermittent porphyria (AIP). Journal of medical economics. pp. 1441-1449. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Massachi, S. et al. (2021). Cost savings with hemin versus givosiran for the treatment of patients with acute intermittent porphyria (AIP). Journal of medical economics. pp. 1441-1449. [Online].